Showing 1821-1830 of 9174 results for "".
Practice Cost Savings, Part IV: Banking
https://practicaldermatology.com/topics/practice-management/practice-cost-savings-part-iv-banking/21520/Evaluation and re-evaluation of banking services and relationships is one of the essential elements of any practice.Neal Bhatia, MD
https://practicaldermatology.com/topics/practice-management/neal-bhatia-md/22950/Dr. Neal Bhatia is an Associate Professor of Dermatology at Harbor UCLA and is also in private practice in Long Beach, CA. He has published articles on a wide range of topics covering both medical and cosmetic dermatology, and he completed a oneyear appointment on the AAD Board of Directors. Ahead,Update on NSAIDs and Skin Cancer Prevention
https://practicaldermatology.com/topics/skin-cancer-photoprotection/update-on-nsaids-and-skin-cancer-prevention/21602/As more data point to protection against melanoma and NMSC, clinical implications are still limited.Clinical Decision Support and Point-of-Care Information for Dermatology
https://practicaldermatology.com/topics/practice-management/clinical-decision-support-and-point-of-care-information-for-dermatology/21652/Clinicians need to be aware of the full capabilities and benefits of available tools and how they can be used most efficiently.Cosmetics Challenge: Six Strategies for Scientific Skincare, Part 2 of 2
https://practicaldermatology.com/topics/general-topics/cosmetics-challenge-six-strategies-for-scientific-skincare-part-2-of-2/21934/Clinicians who are familiar with scientifically proven skincare ingredients, knowledgeable about formulations, and adept at combining topical products can help patients achieve or maintain cosmetic rejuvenation goals.High Risk SCC: What Factors Predict Recurrence and Metastasis?
https://practicaldermatology.com/topics/general-topics/PD1208_12-php/22609/Data shed light on risk factors associated with aggressive SCC, allowing dermatologists to identify and properly follow high-risk patients.Verrucous Psoriasis: A Rare Variant Refractory to Topical Steroids
https://practicaldermatology.com/programs/practical-dermatology-focus-psoriasis/verrucous-psoriasis-a-rare-variant-refractory-to-topical-steroids/29204/In this case study, researchers present a patient with VP of the dorsal fingers that was initially diagnosed as psoriasis and treated with multiple topical steroids. Ultimately, the patient was refractory to steroid topical therapy and required consideration of alternative treatments for definitiveProfessionalism in the Workplace: Tips for Managers
https://practicaldermatology.com/topics/practice-management/professionalism-in-the-workplace-tips-for-managers/20514/Maintaining the highest possible level of professionalism can help new and seasoned managers navigate challenges and position themselves to take advantage of additional opportunities.Psoriasis Treatment in 2025: More Options, Better Outcomes
https://practicaldermatology.com/issues/august-2025/psoriasis-treatment-in-2025-more-options-better-outcomes/36706/We have better drugs to treat psoriasis than almost any other dermatologic disease state. For patients, it is an excellent time to have psoriasis.Systemic Corticosteroids, Chronic Inflammatory Skin Disease, and COVID-19: What Do We Know?
https://practicaldermatology.com/topics/infections-infectious-disease/systemic-corticosteroids-chronic-inflammatory-skin-disease-and-covid-19-what-do-we-know/23615/An assessment of the risk of COVID-19 infection imposed by systemic corticosteroid use in the setting of chronic inflammatory skin disease.